^
    Back
    Association details:
    Biomarker:No biomarker
    Cancer:Gastroesophageal Junction Adenocarcinoma
    Regimen:DOF
    Direction:Sensitive
    Evidence:
    Evidence Level:
    Sensitive: A2 - Guideline
    New
    Source:
    NCCN
    Excerpt:
    Gastroesophageal Junction Adenocarcinoma: Principles of systemic therapy…Other recommended regimens…Docetaxel, cisplatin or oxaliplatin, and fluorouracil